Search research articles
Contact Us
Filters
Showing results (611-620 of 644) with videos related to
Page
of 65
Sort By:
The Journal of Investigative Dermatology
|
June 9, 2000
Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1
J H Xia, Y F Yang, H Deng, et al.
Nature Communications
|
November 23, 2021
In-plane quasi-single-domain BaTiO<sub>3</sub> via interfacial symmetry engineering
J W Lee, K Eom, T R Paudel, et al.
Physical Review Letters
|
October 15, 2008
Strain-induced polarization rotation in epitaxial (001) BiFeO3 thin films
H W Jang, S H Baek, D Ortiz, et al.
Alimentary Pharmacology & Therapeutics
|
October 31, 2023
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks
Scott K Fung, Calvin Q Pan, Grace Lai-Hung Wong, et al.
Nature Communications
|
July 29, 2018
Chemically specific termination control of oxide interfaces via layer-by-layer mean inner potential engineering
H Y Sun, Z W Mao, T W Zhang, et al.
Nature Genetics
|
December 8, 1998
Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment
J H Xia, C Y Liu, B S Tang, et al.
Neuron
|
September 1, 2023
Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice
Zohreh Farsi, Ally Nicolella, Sean K Simmons, et al.
Oncogene
|
December 23, 2014
SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma
P Y Hernanda, K Chen, A M Das, et al.
Translational Psychiatry
|
February 19, 2020
Effects of a patient-derived de novo coding alteration of CACNA1I in mice connect a schizophrenia risk gene with sleep spindle deficits
Ayan Ghoshal, David S Uygun, Lingling Yang, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Maria Buti, Edward Gane, Wai Kay Seto, et al.
Page
of 65
Search research articles
Search
Showing results (611-620 of 644) with videos related to
Sort By:
Page
of 65
The Journal of Investigative Dermatology
|
June 9, 2000
Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1
J H Xia, Y F Yang, H Deng, et al.
Nature Communications
|
November 23, 2021
In-plane quasi-single-domain BaTiO<sub>3</sub> via interfacial symmetry engineering
J W Lee, K Eom, T R Paudel, et al.
Physical Review Letters
|
October 15, 2008
Strain-induced polarization rotation in epitaxial (001) BiFeO3 thin films
H W Jang, S H Baek, D Ortiz, et al.
Alimentary Pharmacology & Therapeutics
|
October 31, 2023
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks
Scott K Fung, Calvin Q Pan, Grace Lai-Hung Wong, et al.
Nature Communications
|
July 29, 2018
Chemically specific termination control of oxide interfaces via layer-by-layer mean inner potential engineering
H Y Sun, Z W Mao, T W Zhang, et al.
Nature Genetics
|
December 8, 1998
Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment
J H Xia, C Y Liu, B S Tang, et al.
Neuron
|
September 1, 2023
Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice
Zohreh Farsi, Ally Nicolella, Sean K Simmons, et al.
Oncogene
|
December 23, 2014
SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma
P Y Hernanda, K Chen, A M Das, et al.
Translational Psychiatry
|
February 19, 2020
Effects of a patient-derived de novo coding alteration of CACNA1I in mice connect a schizophrenia risk gene with sleep spindle deficits
Ayan Ghoshal, David S Uygun, Lingling Yang, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Maria Buti, Edward Gane, Wai Kay Seto, et al.
Page
of 65